Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
批准号:
9124324
负责人:
Gulab Zode
金额:
$32.85万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-01 至 2021-02-27
关键词:
AnteriorApoptosisApoptoticAqueous HumorAutophagocytosisBlindnessCRISPR/Cas technologyCell DeathCell SurvivalCellsCellular StressChronicDegradation PathwayDevelopmentDexamethasoneDiseaseDisease ProgressionEndoplasmic ReticulumEquilibriumEyeFunctional disorderGlaucomaHomeostasisHumanKnockout MiceLeadLinkMediatingModelingMusOrgan Culture TechniquesPathway interactionsPeptidesPerfusionPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProteinsRecoveryRegulationResistanceRisk FactorsRoleSignal TransductionSystemTissuesTrabecular meshwork structureactivating transcription factor 4basecommon treatmentendoplasmic reticulum stressgenome editingimprovedinhibition of autophagyinsightlink proteinmouse modelmutantmyocilinnew therapeutic targetnovelpreventprotective effectprotein misfoldingpublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Primary open angle glaucoma, a major cause of irreversible blindness, is often associated with elevated intraocular pressure (IOP) due to increased aqueous humor outflow resistance at the trabecular meshwork (TM). The pathological mechanisms leading to increased outflow resistance and IOP elevation are poorly understood. We recently linked protein misfolding and endoplasmic reticulum (ER) stress to the development of glaucomatous TM damage and IOP elevation. TM cells activate protective unfolded protein response (UPR) pathway to eliminate abnormal protein accumulation. However chronic ER stress leads to induction of terminal UPR signals including ATF4 and CHOP that are known to induce cell death. Interestingly, human glaucomatous TM tissues also show significantly increased ATF4 and CHOP. Moreover, deletion of Chop protects from ER stress and IOP elevation in mouse models of glaucoma. It is not clear how ATF4 and CHOP cause TM dysfunction and IOP elevation. In our preliminary studies, we discovered that increased ATF4 or CHOP is associated with impaired autophagy, a lysosomal degradation pathway in the TM of human and murine glaucoma. Moreover, correction of impaired autophagy via specific activator of autophagy Tat-beclin1 peptide reduces elevated IOP in mouse model of glaucoma. Based on these findings, we hypothesize that during ocular chronic ER stress, the balance between pro-cell death ATF4 and CHOP and pro-survival corrective autophagic pathways determine glaucomatous TM disease progression. The specific aims of this proposal are: (1) To determine whether ATF4 and CHOP impair autophagic function, induce TM cell death and elevate IOP in WT mice, (2) Determine whether ATF-4 or CHOP deficiency prevents IOP elevation by improving autophagic function in the TM of Tg-MYOCY437H mice, and (3) Determine whether enhancing autophagic flux by Tat-beclin 1 peptide reduces elevated IOP in mouse models of glaucoma and in the human anterior segment perfusion culture model. These studies will utilize cultured human TM cells, mouse models of glaucoma and human anterior segment organ culture model to examine the interactions between ATF4, CHOP and autophagy in TM mediated IOP regulation. The proposed study will provide a link between UPR and autophagy and investigate whether manipulation of these pathways can provide protection against glaucoma. These studies will further explore the possibility of treating glaucoma using Tat-beclin 1 peptide in degradation of abnormal protein accumulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and characterization of an inducible model for myocilin POAG
-
批准号:10661911
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2023
-
负责人:Gulab Zode
-
依托单位:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
-
批准号:10202609
-
项目类别:
-
资助金额:$35.41万
-
财政年份:2018
-
负责人:Gulab Zode
-
依托单位:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
-
批准号:9788452
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2018
-
负责人:Gulab Zode
-
依托单位:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
-
批准号:10850091
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2016
-
负责人:Gulab Zode
-
依托单位:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
-
批准号:10445174
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2016
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8822297
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8813843
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:9039612
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8383990
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2012
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8534133
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2012
-
负责人:Gulab Zode
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: